Shimadzu Corporation announced its results for the first quarter of the fiscal year ending March 2027. Revenue reached a record high, while operating profit and net income also rose sharply. The next earnings announcement is scheduled for 6 November, and the company indicated that a dividend increase is also expected.
Shimadzu Corporation published its earnings report for the first quarter of the fiscal year ending March 2027 on 6 August 2026. Revenue rose 10.3% year on year to ¥130.6 billion, a record high, while operating profit increased 17.1% to ¥14.3 billion and net income attributable to owners of the parent rose 68.3% to ¥13.3 billion. The full-year earnings forecast was also revised upward, and a dividend increase is planned.
A summary issued on 9 August 2026 indicated that performance had been improving over the past 12 quarters, with net and operating margins recovering, while the equity ratio continued to rise and EPS continued to increase.
The share price rose 3.8%, from a closing price of ¥4,329 on 21 October to ¥4,494 on 28 October. Over the past 5 trading days, it has maintained an upward trend despite trading in the low ¥4,300 range. The reported development of the world's first automated metabolomics analysis system on 21 October coincided with the share price recovery.